Chemoinformaics analysis of Kaempferide 3-rhamnoside
| Molecular Weight | 446.408 | nRot | 4 |
| Heavy Atom Molecular Weight | 424.232 | nRig | 24 |
| Exact Molecular Weight | 446.121 | nRing | 4 |
| Solubility: LogS | -4.176 | nHRing | 2 |
| Solubility: LogP | 2.104 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 59.4294 |
| nHD | 5 | BPOL | 29.8826 |
| QED | 0.393 |
| Synth | 3.806 |
| Natural Product Likeliness | 1.894 |
| NR-PPAR-gamma | 0.924 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.058 |
| Pgp-sub | 0.717 |
| HIA | 0.067 |
| CACO-2 | -5.768 |
| MDCK | 0.0000139 |
| BBB | 0.021 |
| PPB | 0.895911 |
| VDSS | 0.944 |
| FU | 0.0989594 |
| CYP1A2-inh | 0.278 |
| CYP1A2-sub | 0.343 |
| CYP2c19-inh | 0.076 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.203 |
| CYP2c9-sub | 0.897 |
| CYP2d6-inh | 0.613 |
| CYP2d6-sub | 0.374 |
| CYP3a4-inh | 0.223 |
| CYP3a4-sub | 0.048 |
| CL | 4.779 |
| T12 | 0.706 |
| hERG | 0.031 |
| Ames | 0.778 |
| ROA | 0.048 |
| SkinSen | 0.083 |
| Carcinogencity | 0.089 |
| EI | 0.042 |
| Respiratory | 0.053 |
| NR-Aromatase | 0.902 |
| Antiviral | Yes |
| Prediction | 0.935527 |